ArticleWorld journal of surgical oncology2014

High p-Smad2 expression in stromal fibroblasts predicts poor survival in patients with clinical stage I to IIIA non-small cell lung cancer.

Yongbing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.